Evaluation of Patient Assistance Program Eligibility and Availability for Top 200 Brand Name and Generic Drugs in the United States
One strategy to encourage uninsured and underinsured patients' compliance with medication regimen is to refer them to pharmaceutical industry-sponsored patient assistance programs (PAPs). In order to receive the requested medications, patients should be qualified based on the program eligibilit...
Saved in:
Main Authors: | Chin-Fun Chu (Author), Lincy S Lal (Author), Tisha M Felder (Author), Pauline Rosenau (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Patient Assistance Program Eligibility and Availability for Top 200 Brand Name and Generic Drugs in the United States
by: Chin-Fun Chu, et al.
Published: (2012) -
The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013) -
Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
by: Ping Yang, et al.
Published: (2021) -
Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
by: Bosak M, et al.
Published: (2017) -
Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
by: Ochi N, et al.
Published: (2014)